BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/12/2014 8:40:00 PM | Browse: 247 | Download: 146
Publication Name World Journal of Gastroenterology
Manuscript ID 3018
Country of Manuscript Source South Korea
2013-04-02 20:28
Peer-Review Started
2013-04-04 17:18
To Make the First Decision
2013-05-02 09:03
Return for Revision
2013-05-17 18:32
2013-05-20 11:37
Second Decision
2013-08-06 08:34
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2013-08-06 11:42
Articles in Press
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2013-09-16 21:43
Publish the Manuscript Online
2013-10-18 17:02
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7901 Stoneridge Drive, Suite 501, Pleasanton, CA 94588, USA
Website http://www.wjgnet.com
Specialty Gastroenterology and Hepatology
Manuscript Type Review
Article Title Molecular targeted therapy for hepatocellular carcinoma: Current and future
Manuscript Source Invited Manuscript
All Author List Jung Woo Shin and Young-Hwa Chung
Funding Agency and Grant Number
Correspondence To Young-Hwa Chung, MD, PhD, Professor, Department of Internal Medicine, University of Ulsan College of Medicine, Asan Medical Center, 86 Asanbyeongwon-gil, Songpa-gu, Seoul 138-736, South Korea. yhchung@amc.seoul.kr
Keywords Hepatocellular carcinoma; Targeted therapy; Molecular agents; Sorafenib
Core Tip Sorafenib is the first drug to prolong survival of patients with advanced hepatocellular carcinoma (HCC). This advance has shifted the paradigm of systemic treatment for HCC toward molecular targeted therapy. This review aims to summarize the efforts to target molecular components of the signaling pathways that are responsible for the development and progression of HCC and to discuss perspectives on the future direction of research.
Publish Date 2013-10-18 17:02
Citation Shin JW, Chung YH. Molecular targeted therapy for hepatocellular carcinoma: Current and future. World J Gastroenterol 2013; 19(37): 6144-6155
Url http://www.wjgnet.com/1007-9327/full/v19/i37/6144.htm
DOI http://dx.doi.org/10.3748/wjg.v19.i37.6144
Full Article (PDF) WJG-19-6144.pdf
Revised Manuscript 3018-Review.docx
Peer-review Report 3018-Peer review(s).pdf
Answering Reviewers 3018-Answering reviewers.pdf
Scientific Editor Work List 3018-Scientific editor work list.doc
Copyright License Agreement 3018-Copyright assignment.docx
Non-Native Speakers of English Editing Certificate 3018-Language certificate.pdf